Viewing nowCombinationSelmistar Tablet 40/10 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201605775 · Approved 2016.09.30 · Insurance code 693902370
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using amlodipine or telmisartan.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the tablet at the same time each day (e.g., in the morning). It is recommended to adjust the dose using the individual components (amlodipine or telmisartan) before administering this medicine. However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication may pose a serious risk to the fetus, especially during the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. Individuals with allergies to any of the components of this medication, specific heart diseases, liver disorders, or severe hypotension should not take it. Caution is advised for patients with liver or kidney dysfunction, gastrointestinal diseases, and elderly patients. Side effects such as dizziness, edema, and hypotension may occur during use, and immediate consultation with medical personnel is required in severe cases. This medication may interact with other drugs, so inform your healthcare provider of any medications you are currently taking. Women who are pregnant or breastfeeding should not take this medication, and those planning to become pregnant should consult with healthcare providers before use. It is not recommended for children or adolescents under 18 years of age as safety and efficacy have not been sufficiently established. Overdosage can result in hypotension, dizziness, and cardiac issues, requiring immediate hospital treatment. Store this medication out of reach of children and take it rapidly after opening; it is advised not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that is shielded from light and air, at a temperature between 1°C and 30°C at room temperature. Following these storage conditions helps maintain the drug's efficacy and prevents degradation.
This is a biconvex oval double tablet that is white and light gray.
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.